SHC

As of 2026-09-11, SHC scores 52out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. SHC trades at $18.37, within its fair-value band.

SHC scores 52 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 52. Its strongest factor is value at 69 (strong), where it screens cheap on the model's valuation inputs, followed by sentiment at 55. The weakest is volume at 43, where volume gives little confirmation. Among Healthcare stocks it ranks in roughly the top 26% of the Healthcare names the model scores.

On valuation, SHC is priced around the middle of its recent range. The blended composite before the macro overlay was 53. Same-sector names the model rates nearby include HALO, THC, HNGE.

This is a descriptive factor read on SHC, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where SHC sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for SHC runs $15.63–$21.15. Current price $18.37 sits within its fair-value band. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-11.